McCaffrey T V, Olsen K D, Yohanan J M, Lewis J E, Ebersold M J, Piepgras D G
Department of Otorhinolaryngology, Mayo Clinic, Rochester, MN 55905.
Laryngoscope. 1994 Aug;104(8 Pt 1):940-5. doi: 10.1288/00005537-199408000-00006.
Fifty-four patients with primary neoplasms of the anterior skull base were treated by craniofacial resection with curative intent. The most common tumor was esthesioneuroblastoma (24), followed by squamous cell carcinoma (10). The overall 2-year and 5-year survivals were 75% and 49%, respectively. High-grade tumors, grades 3 and 4, had a poorer prognosis. Tumor size, dural involvement, sphenoid sinus involvement, age, and sex had no significant influence on survival when examined by multivariate survival analysis. Sixteen complications were noted in the postoperative period. Cerebrospinal fluid leakage occurred in 2 patients and loss of frontal bone occurred in 4. There were no operative or perioperative deaths. Craniofacial resection permits surgical resection of the majority of anterior skull base tumors with acceptable morbidity.
54例前颅底原发性肿瘤患者接受了旨在治愈的颅面切除术。最常见的肿瘤是嗅神经母细胞瘤(24例),其次是鳞状细胞癌(10例)。总体2年和5年生存率分别为75%和49%。3级和4级高级别肿瘤预后较差。通过多因素生存分析检查时,肿瘤大小、硬脑膜受累、蝶窦受累、年龄和性别对生存无显著影响。术后出现16例并发症。2例患者发生脑脊液漏,4例患者出现额骨缺失。无手术或围手术期死亡。颅面切除术能够以可接受的发病率对大多数前颅底肿瘤进行手术切除。